Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 20, 2026

Production and Purification of Baculovirus for Gene Therapy Application
06:11

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

Foamy virus vectors for gene transfer.

Grant D Trobridge1

  • 1Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024, USA. gtrobrid@fhcrc.org

Expert Opinion on Biological Therapy
|September 12, 2009
PubMed
Summary

Foamy virus (FV) vectors show promise for gene therapy due to their safety and efficiency. These vectors enable stable gene transfer, particularly to hematopoietic stem cells, with a unique integration profile potentially offering enhanced safety.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mutagenesis Screens for Prostate Cancer Using Replication-Incompetent Lentiviral Vectors.

Methods in molecular biology (Clifton, N.J.)·2018
Same author

Efficacy and safety of a clinically relevant foamy vector design in human hematopoietic repopulating cells.

The journal of gene medicine·2018
Same author

Rapid immune reconstitution of SCID-X1 canines after G-CSF/AMD3100 mobilization and in vivo gene therapy.

Blood advances·2018
Same author

Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes.

Oncotarget·2018
Same author

Prospects for Foamy Viral Vector Anti-HIV Gene Therapy.

Biomedicines·2017
Same author

Insulators to Improve the Safety of Retroviral Vectors for HIV Gene Therapy.

Biomedicines·2017

Area of Science:

  • Gene therapy
  • Retroviral vectors
  • Molecular biology

Background:

  • Foamy viruses (FVs) are spumaretroviruses prevalent in nonhuman primates and mammals, not endemic in humans.
  • FVs exhibit efficient horizontal transmission without causing pathology.
  • FV vectors offer unique properties for gene therapy, including safety, broad tropism, large transgene capacity, and persistence in quiescent cells.

Purpose of the Study:

  • To discuss the properties of FVs relevant to the safety and efficacy of FV vectors for gene therapy.
  • To review the development of FV vector systems.
  • To evaluate the potential of FV vectors in vitro and in preclinical animal models.

Main Methods:

  • Review of existing literature on Foamy virus vector systems.
  • Analysis of FV vector integration sites in vitro and in hematopoietic repopulating cells.
  • Evaluation of gene transfer efficiency and stability in preclinical models.

Main Results:

  • FV vectors demonstrate efficient and stable gene transfer to hematopoietic stem cells (HSCs) in mouse and canine models.
  • FV vectors possess a unique integration profile, suggesting a potentially safer alternative to gammaretroviruses and lentiviral vectors.
  • Preclinical studies indicate promising safety and efficacy of FV vectors.

Conclusions:

  • Foamy virus vectors are efficient gene delivery vehicles with a favorable safety profile for gene therapy applications.
  • Their unique integration characteristics may offer advantages over existing retroviral vectors.
  • Further development and evaluation in preclinical models support the therapeutic potential of FV vectors.

More Related Videos

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling
21:55

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012

Related Experiment Videos

Last Updated: Jun 20, 2026

Production and Purification of Baculovirus for Gene Therapy Application
06:11

Production and Purification of Baculovirus for Gene Therapy Application

Published on: April 9, 2018

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling
21:55

Engineering and Evolution of Synthetic Adeno-Associated Virus (AAV) Gene Therapy Vectors via DNA Family Shuffling

Published on: April 2, 2012